These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3575793)

  • 1. Strengths and weaknesses of long-term bioassays.
    Schach von Wittenau M
    Regul Toxicol Pharmacol; 1987 Mar; 7(1):113-9. PubMed ID: 3575793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemicals studied and evaluated in long-term carcinogenesis bioassays by both the Ramazzini Foundation and the National Toxicology Program: in tribute to Cesare Maltoni and David Rall.
    Huff J
    Ann N Y Acad Sci; 2002 Dec; 982():208-30. PubMed ID: 12562639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996.
    Gold LS; Manley NB; Slone TH; Rohrbach L
    Environ Health Perspect; 1999 Aug; 107 Suppl 4(Suppl 4):527-600. PubMed ID: 10421768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The National Toxicology Program rodent bioassay: designs, interpretations, and scientific contributions.
    Bucher JR
    Ann N Y Acad Sci; 2002 Dec; 982():198-207. PubMed ID: 12562638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing of chemicals for carcinogenic activities and some problems related to the assessment of carcinogenic risks to men.
    Schramm T; Teichmann B
    Pol J Pharmacol Pharm; 1979; 31(6):639-45. PubMed ID: 550120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of the number of liver carcinogens in bioassays conducted by the National Toxicology Program.
    Crump KS; Krewski D; Wang Y
    Risk Anal; 1998 Jun; 18(3):299-308. PubMed ID: 9664726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
    Osimitz TG; Droege W; Boobis AR; Lake BG
    Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening of chemicals and tests for carcinogenicity - part of comprehensive toxicological investigation].
    Schramm T; Teichmann B
    Nahrung; 1981; 25(2):167-73. PubMed ID: 7242655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental design constraints on carcinogenic potency estimates.
    Rieth JP; Starr TB
    J Toxicol Environ Health; 1989; 27(3):287-96. PubMed ID: 2754755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical carcinogens: screening, testing, risk assessment for man.
    Schramm T; Teichmann B
    Neoplasma; 1981; 28(2):129-31. PubMed ID: 7254431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical perspective on the use of animal bioassays to predict carcinogenicity: evolution in design and recognition of utility.
    Beyer LA; Beck BD; Lewandowski TA
    Crit Rev Toxicol; 2011 Apr; 41(4):321-38. PubMed ID: 21438739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay.
    Cohen SM
    Toxicol Sci; 2004 Aug; 80(2):225-9. PubMed ID: 15129023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human carcinogenic risk evaluation, Part V: The national toxicology program vision for assessing the human carcinogenic hazard of chemicals.
    Bucher JR; Portier C
    Toxicol Sci; 2004 Dec; 82(2):363-6. PubMed ID: 15456919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fifth plot of the Carcinogenic Potency Database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989.
    Gold LS; Manley NB; Slone TH; Garfinkel GB; Rohrbach L; Ames BN
    Environ Health Perspect; 1993 Apr; 100():65-168. PubMed ID: 8354183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enhanced thirteen-week bioassay as an alternative for screening for carcinogenesis factors.
    Cohen SM
    Asian Pac J Cancer Prev; 2010; 11(1):15-7. PubMed ID: 20593920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternatives to the 2-species bioassay for the identification of potential human carcinogens.
    Ashby J
    Hum Exp Toxicol; 1996 Mar; 15(3):183-202. PubMed ID: 8839204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls in assessing risks from carcinogens.
    Furst A
    Biomed Environ Sci; 1991 Sep; 4(3):242-9. PubMed ID: 1764213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.